Knee Implant Current Affairs - 2020
The scientists of Advanced Research Centre for powder metallurgy and new materials along with Sree Chitra Tirunal Institute of Medical Sciences (SCTIMST) have developed new biodegradable implant. The implants were developed from Iron-Manganese alloy.
The alloy is highly applicable for making biodegradable orthopedic implant applications and stents. These implants participate in the healing process and gradually degrade maintaining the mechanical integrity. They do not leave out any residues in the human body. They are certainly better alternatives to current implants.
During the degradation process, calcium phosphate deposits on the implants. This is caused due to local alkalization. When the calcium and phosphates getting deposited gets saturated, they allow the cells they allow the cells to form into tissues forming tissues.
The current implants cause long term side effects such as toxicity, thrombosis and chronic inflammation. These side effects are not present in biodegradable implants. The bio degradable materials are iron, zinc and manganese.
Tags: all implantable devices • bone implant materials • Health • Knee Implant • Medicine
Government has notified that ceiling price of orthopaedic knee implants will be monitored to ensure that their cost does not increase beyond 10% in a given year.
Earlier on 16 August 2017, National Pharmaceutical Pricing Authority (NPPA) notified ceiling price of orthopaedic knee implants by invoking extraordinary powers, in public interest, under Para 19 of Drugs Prices Control Order (DPCO) 2013, for a period of 1 year. Subsequently a notification was issued dated 13 August 2018, the applicability of ceiling prices fixed for orthopaedic knee implants was extended for another 1 year period i.e. up to 15 August 2019.
This led to the reduction in cost of knee implants significantly, up to 69%, resulting in a notional saving of Rs.1500 crore per annum to consumers.
At a meeting held on 8 August 2019, NPPA reviewed the sales of knee implants matter and noted that there has been an increased access due to knee implants becoming affordable. As per data submitted by manufacturers and importers, during period of July 2018 to June 2019, an increase of 30% in sales of knee implants was reported.
Though the medical industry has requested for a 20% (10% for year 2018 and 10% for 2019) increase in price of knee implants, government decided to further monitor price increase of knee implants as per para 20 of Drugs Prices Control Order (DPCO) 2013 that restricts price increase beyond 10% in a given year which shall be subject to a review after 1 year period.
About Knee Implant:
It is a non-scheduled medical device or drug for which Drugs Prices Control Order (DPCO), 2013 allows an annual increase upto 10% of MRP (Maximum retail price). However this was not permitted in 2018.
What is National Pharmaceutical Pricing Authority?
NPPA is independent body of experts that controls prices of pharmaceutical drugs in India. It is government regulatory agency formed on 29 August 1997.
It functions under Union Ministry of Chemicals and Fertilizers to implement and enforce provisions of Drugs Prices Control Order (DPCO) for regulating medicine prices in accordance with powers delegated to it.
DPCO is an order issued by government under ‘Essential Commodities Act’ which enables it to fix prices of some essential bulk drugs as well as their formulations.